The human mouth, or oral cavity, is at the crossroads of our external and internal environments, and it is increasingly evident that local colonization of dental, oral, and craniofacial (DOC) tissues and cells by bacteria and viruses may also have systemic effects across myriad diseases and disorders. Better understanding of this phenomenon will require a holistic understanding of host-microbial interactions in both spatiotemporal and biogeographical contexts while also considering person-, organ-, tissue-, cell-, and molecular-level variation. After the acute phase interaction with microbes, the establishment of site-specific reservoirs constitutes an important relationship to understand within the human body; however, despite a preliminary understanding of how viral reservoirs originate and persist across the human body, the landscape of single-cell and spatial multiomic tools has challenged our current understanding of what cells and niches can support microbial reservoirs. The lack of complete understanding impacts research into these relevant topics and implementing precision care for microbial-induced or microbial-influenced diseases. Here, via the lens of acute and chronic microbial infections of the DOC tissues, the goal of this review is to highlight and link the emerging spatiotemporal biogeography of host-viral interactomics at 3 levels: (1) DOC cell types in distinct tissues, (2) DOC-associated microbes, and (3) niche-specific DOC pathologies. Further, we will focus on the impact of postacute infectious syndromes such as long COVID, neurodegenerative disorders, and other underappreciated postviral conditions. We will provide hypotheses about how DOC tissues may play roles systemically in these conditions. Throughout, we will underscore how COVID-19 has catalyzed a new understanding of these biological questions, discuss future directions to study these phenomena, and highlight the utility of noninvasive oral biofluids in screening, monitoring, and intervening to prevent and/or ameliorate human infectious diseases.
ApostolouERizwanMMoustardasPSjögrenPBertilsonBCBragéeBPoloORosénA. 2022. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome. Front Immunol. 13:949787.
2.
BedardMCChihangaTCarlileAJacksonRBrusadelliMGLeeDVonHandorfARochmanMDexheimerPJChalmersJ, et al. 2023. Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer. Nat Commun. 14(1):1975.
3.
BenfieldAHHenriquesST. 2020. Mode-of-action of antimicrobial peptides: membrane disruption vs. intracellular mechanisms. Front Med Technol. 2:610997.
4.
BonamSRMullerS. 2020. Parkinson’s disease is an autoimmune disease: a reappraisal. Autoimmun Rev. 19(12):102684.
5.
BrookI. 2009. The bacteriology of salivary gland infections. Oral Maxillofac Surg Clin North Am. 21(3):269–274.
6.
ByrdKMGulatiAS. 2021. The “gum-gut” axis in inflammatory bowel diseases: a hypothesis-driven review of associations and advances. Front Immunol. 12:620124.
7.
CaetanoAJ, Human Cell Atlas Oral and Craniofacial Bionetwork, SequeiraIByrdKM. 2022. A roadmap for the human oral and craniofacial cell atlas. J Dent Res. 101(11):1274–1288.
8.
CaetanoAJYianniVVolponiABoothVD’AgostinoEMSharpeP. 2021. Defining human mesenchymal and epithelial heterogeneity in response to oral inflammatory disease. ELife. 10:e62810.
ChangRYen-Ting ChenTWangSIHungYMChenHYWeiCJ. 2023. Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study. EClinicalMedicine. 56:101783.
CobbsC. 2019. Cytomegalovirus is a tumor-associated virus: armed and dangerous. Curr Opin Virol. 39:49–59.
13.
CorstjensPLAbramsWRMalamudD. 2016. Saliva and viral infections. Periodontol2000. 70(1):93–110.
14.
Costa-da-SilvaACAureMHDodgeJMartinDDhamalaSChoMRoseJJBassimCWAmbatipudiKHakimFT, et al. 2022. Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease. iScience. 25(1):103592.
15.
DavisHEMcCorkellLVogelJMTopolEJ. 2023. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 21(3):133–146.
16.
DevauxCAMezouarSMegeJL. 2019. The e-cadherin cleavage associated to pathogenic bacteria infections can favor bacterial invasion and transmigration, dysregulation of the immune response and cancer induction in humans. Front Microbiol. 10:2598.
17.
DominySSLynchCErminiFBenedykMMarczykAKonradiANguyenMHaditschURahaDGriffinC, et al. 2019. Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 5(1):eaau3333.
ErenAMBorisyGGHuseSMMark WelchJL. 2014. Oligotyping analysis of the human oral microbiome. Proc Natl Acad Sci U S A. 111(28):E2875–E2884.
20.
Fernandes MatuckBDolhnikoffMMaiaGVAIsaac SendykDZarpellonACosta GomesSDuarte-NetoANRebello PinhoJRGomes-GouvêaMSSousaS, et al. 2020. Periodontal tissues are targets for Sars-Cov-2: a post-mortem study. J Oral Microbiol. 13(1):1848135.
21.
Fernandes MatuckBFerraz da SilvaLFWarnerBMByrdKM. 2023. The need for integrated research autopsies in the era of precision oral medicine. J Am Dent Assoc. 154(3):194–205.
22.
FitzpatrickSGCohenDMClarkAN. 2019. Ulcerated lesions of the oral mucosa: clinical and histologic review. Head Neck Pathol. 13(1):91–102.
23.
FournierBBoutboulDBruneauJMiotCBoulangerCMalphettesMPellierIDunoguéBTerrierBSuarezF, et al. 2020. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection. J Exp Med. 217(11):e20192262.
24.
GaoY-DDingMDongXZhangJ-JKursat AzkurAAzkurDGanHSunY-LFuWLiW, et al. 2021. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 76(2):428–455.
25.
GhoshSKumarMSantianaMMishraAZhangMLabayoHChiblyAMNakamuraHTanakaTHendersonW, et al. 2022. Enteric viruses replicate in salivary glands and infect through saliva. Nature. 607(7918):345–350.
26.
GilbertsonBEdenboroughKMcVernonJBrownLE. 2019. Inhibition of influenza A virus by human infant saliva. Viruses. 11(8):766.
27.
GrantMKilsgårdOÅkermanSKlingeBDemmerRTMalmströmJJönssonD. 2019. The human salivary antimicrobial peptide profile according to the oral microbiota in health, periodontitis and smoking. J Innate Immun. 11(5):432–444.
28.
GriffinDE. 2022. Why does viral RNA sometimes persist after recovery from acute infections?PLoS Biol. 20(6):e3001687.
29.
GroegerSMeyleJ. 2019. Oral mucosal epithelial cells. Front Immunol. 10:208.
30.
GuimarãesDPissarraRReis-MeloAGuimarãesH. 2021. Multisystem inflammatory syndrome in children (MISC): a systematic review. Int J Clin Pract. 75(11):e14450.
31.
GuptaSMohindraRChauhanPKSinglaVGoyalKSahniVGaurRVermaDKGhoshASoniRK, et al. 2021. SARS-CoV-2 detection in gingival crevicular fluid. J Dent Res. 100(2):187–193.
32.
HaranJPBradleyEZeamerALCincottaLSaliveMCDuttaPMutaaweSAnyaOMeza-SeguraMMoormannAM, et al. 2021. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight. 6(20):e152346.
33.
HartshornKLWhiteMRTecleTHolmskovUCrouchEC. 2006. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J Immunol. 176(11):6962–6972.
34.
HouYJOkudaKEdwardsCEMartinezDRAsakuraTDinnonKHIIIKatoTLeeREYountBLMascenikTM, et al. 2020. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 182(2):429–446.e14.
35.
HouenGTrierNH. 2021. Epstein-Barr virus and systemic autoimmune diseases. Front Immunol. 11:587380.
36.
HuangNPérezPKatoTMikamiYOkudaKGilmoreRCCondeCDGasmiBSteinSBeachM, et al. 2021. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 27(5):892–903.
37.
HuloCde CastroEMassonPBougueleretLBairochAXenariosILe MercierP. 2011. Viralzone: a knowledge resource to understand virus diversity. Nucleic Acids Res. 39(Database issue):D576–D582.
38.
JamiesonGAMaitlandNJWilcockGKCraskeJItzhakiRF. 1991. Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains. J Med Virol. 33(4):224–227.
39.
JeffersLWebster-CyriaqueJY. 2011. Viruses and salivary gland disease (SGD): lessons from HIV SGD. Adv Dent Res. 23(1):79–83.
40.
JiSChoiY. 2020. Microbial and host factors that affect bacterial invasion of the gingiva. J Dent Res. 99(9):1013–1020.
41.
KincerLPJosephSBGilleeceMMHauserBMSizemoreSZhouSDi GermanioCZetterbergHFuchsDDeeksSG, et al. 2023. Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus. Nat Microbiol. 8(2):260–271.
42.
La RosaGRMLibraMDe PasqualeRFerlitoSPedullàE. 2020. Association of viral infections with oral cavity lesions: role of SARS-CoV-2 infection. Front Med (Lausanne). 7:571214.
43.
LevineKSLeonardHLBlauwendraatCIwakiHJohnsonNBandres-CigaSFerrucciLFaghriFSingletonABNallsMA. 2023. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 111(7):1086–1093.e2.
44.
LiuZChuA. 2021. Sjögren’s syndrome and viral infections. Rheumatol Ther. 8(3):1051–1059.
45.
MadissoonEOliverAJKleshchevnikovVWilbrey-ClarkAPolanskiKRichozNRibeiro OrsiAMamanovaLBoltLElmentaiteR, et al. 2023. A spatially resolved atlas of the human lung characterizes a gland-associated immune niche. Nat Genet. 55(1):66–77.
46.
MarchesanJTWarnerBMByrdKM. 2021. The “oral” history of COVID-19: primary infection, salivary transmission, and post-acute implications. J Periodontol. 92(10):1357–1367.
47.
Mark WelchJLDewhirstFEBorisyGG. 2019. Biogeography of the oral microbiome: the site-specialist hypothesis. Annu Rev Microbiol. 73:335–358.
48.
Mark WelchJLRossettiBJRiekenCWDewhirstFEBorisyGG. 2016. Biogeography of a human oral microbiome at the micron scale. Proc Natl Acad Sci U S A. 113(6):E791–E800.
49.
Martelli JúniorHGueirosLAde LucenaEGColettaRD. 2022. Increase in the number of Sjögren’s syndrome cases in Brazil in the COVID-19 era. Oral Dis. 28 Suppl2:2588–2590.
50.
MothesRPascual-ReguantAKoehlerRLiebeskindJLiebheitABauherrSPhilipsenLDittmayerCLaueMvon ManitiusR, et al. 2023. Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19. Nat Commun. 14(1):791.
51.
NatarajanAZlitniSBrooksEFVanceSEDahlenAHedlinHParkRMHanASchmidtkeDTVermaR, et al. 2022. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 3(6):371–387.e9.
52.
PelusoMJDeeksSGMustapicMKapogiannisDHenrichTJLuSGoldbergSAHohRChenJYMartinezEO, et al. 2022. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann Neurol. 91(6):772–781.
53.
PengXChengLYouYTangCRenBLiYXuXZhouX. 2022. Oral microbiota in human systematic diseases. Int J Oral Sci. 14(1):14.
54.
RajasuoAJousimies-SomerHSavolainenSLeppänenJMurtomaaHMeurmanJH. 1996. Bacteriologic findings in tonsillitis and pericoronitis. Clin Infect Dis. 23(1):51–60.
55.
RajewskyNAlmouzniGGorskiSAAertsSAmitIBerteroMGBockCBredenoordALCavalliGChioccaS, et al. 2020. LifeTime and improving European healthcare through cell-based interceptive medicine. Nature. 587(7834):377–386.
56.
RizzoR. 2020. Controversial role of herpesviruses in Alzheimer’s disease. PLoS Pathog. 16(6):e1008575.
57.
RudneyJDChenRSedgewickGJ. 2001. Intracellular actinobacillus actinomycetemcomitans and porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun. 69(4):2700–2707.
58.
ShineNKonopkaKDüzgüneşN. 1997. The anti-HIV-1 activity associated with saliva. J Dent Res. 76(2):634–640.
59.
ShugarsDCSweetSPMalamudDKazmiSHPage-ShaferKChallacombeSJ. 2002. Saliva and inhibition of HIV-1 infection: molecular mechanisms. Oral Dis. 8Suppl 2:169–175.
60.
SoukupVHorácekICernyR. 2013. Development and evolution of the vertebrate primary mouth. J Anat. 222(1):79–99.
61.
SteinSRRamelliSCGrazioliAChungJYSinghMYindaCKWinklerCWSunJDickeyJMYlayaK, et al. 2022. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 612(7941):758–763.
62.
SunWGaoCHartanaCAOsbornMREinkaufKBLianXBoneBBonheurNChunTWRosenbergES, et al. 2023. Phenotypic signatures of immune selection in HIV-1 reservoir cells. Nature. 614(7947):309–317.
TomovVTPalkoOLauCWPattekarASunYTachevaRBengschBManneSCosmaGLEisenlohrLC, et al. 2017. Differentiation and protective capacity of virus-specific CD8+ T cells suggest murine norovirus persistence in an immune-privileged enteric niche. Immunity. 47(4):723–738.e5.
65.
TravagliniKJNabhanANPenlandLSinhaRGillichASitRVChangSConleySDMoriYSeitaJ, et al. 2020. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature. 587(7835):619–625.
66.
VeenhuisRTAbreuCMCostaPAGFerreiraEARatliffJPohlenzLShirkENRubinLHBlanksonJNGamaL, et al. 2023. Monocyte-derived macrophages contain persistent latent HIV reservoirs. Nat Microbiol. 8(5):833–844.
67.
WeaverDF. 2023. Alzheimer’s disease as an innate autoimmune disease (AD2): a new molecular paradigm. Alzheimers Dement. 19(3):1086–1098.
68.
WilliamsDWGreenwell-WildTBrenchleyLDutzanNOvermillerASawayaAPWebbSMartinD, NIDCD/NIDCR Genomics and Computational Biology Core, HajishengallisG, et al. 2021. Human oral mucosa cell atlas reveals a stromal-neutrophil axis regulating tissue immunity. Cell. 184(15):4090–4104.e15.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
